BiognoSYS has developed a paradigm shifting proteomics platform. It provides patented tools to enable faster discovery of biomarkers that will play a pivotal role in tomorrow’s more personalized medicine. Biomarkers will accelerate the drug development process, provide better diagnosis, and allow patient specific treatment schemes.